Category

EVP Dr. Deepak Kotak to Address the OTC Pharma Asia Conference FREDERICK, MD, USA, November 5, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer and healthcare medical devices announced today that its Executive Vice President, Dr. Deepak Kotak has been invited to present BioElectronics’ innovative chronic pain therapy at the OTC … Continue Reading

FREDERICK, MD, USA, October 27, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today released updated results of its “Try It and Tell Us” 7-day ActiPatch sample program for United Kingdom and Ireland residents who were surveyed about their experience. The data now includes responses from 856 consumers … Continue Reading

FREDERICK, MD, USA, August 26, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today released the updated results of its “Try It and Tell Us” 7-day ActiPatch sample program for United Kingdom and Ireland residents who were surveyed about their experience. Overall results for chronic musculoskeletal pain showed … Continue Reading

Dr. Kotak Shares BioElectronics Opportunities in New Markets   FREDERICK, MD, USA, August 19, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices said that its EVP Dr. Deepak Kotak was interviewed by CEOLIVE.TV as part of its Executive Interview Series. The entire interview is available at http://ceolive.tv/bioelectronics-corp-otc-biel/biel-videos/2282-ceolive-tv-interview-bioelectronics-corp-otcqb-biel In the … Continue Reading

August 4, 2014 Dear BIEL Shareholders: BioElectronics Corporation’s mission is to change the way people heal and relieve their pain.  As the chart below, that clearly demonstrates that, we have done exactly that. Chronic pain sufferers in the United Kingdom said that ActiPatch reduced their pain by more than 50%.  This is what the BioElectronics … Continue Reading

UK Consumers Report ActiPatch® Therapy Reduces Pain, Including Fibromyalgia, Without Drugs FREDERICK, MD, USA, June 30, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today announced positive early feedback from its “Try It and Tell Us” social media program in the United Kingdom that has attracted thousands of followers.  The … Continue Reading

New study shows RecoveryRx®  reduces pain and inflammation and accelerates healing FREDERICK, MD, USA, March 25, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that Dr. Bartolomeo Operti MD, Chief of Anesthesia Department Day Hospital Section of Maria Adelaide Hospital and Dr. Tiziano Tealdo, Clinical Instructor at … Continue Reading

Interview Scheduled at 11:30am PDT / 12:30pm MDT / 2:30pm EDT on the Traders Network Radio Show, Hosted by Michael Yorba FREDERICK, Md., (March 24, 2014) – BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, today announced that CEO Andrew Whelan will be interviewed live Wednesday by host Michael Yorba on Clear Channel Business … Continue Reading

Investors will be able to trade more easily and online FREDERICK, MD, USA, March 20, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that the Depository Trust Company has determined to end the deposit transaction restriction (the Deposit Chill) it had previously placed on shares of BioElectronics. … Continue Reading

Overwhelming Response to RecoveryRx® Fuels Product Portfolio Expansion FREDERICK, MD, USA,/ITALY March 18, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that Biomax, Inc. and One Globe Biotechnology LLC will exclusively distribute ActiPatch® and Allay® Therapy to Austria’s population of over eight million. Biomax, Inc. and One … Continue Reading